Kunath, A.* ; Weiner, J.* ; Krause, K.* ; Rehders, M.* ; Pejkovska, A.* ; Gericke, M.* ; Biniossek, M.L.* ; Dommel, S.* ; Kern, M.* ; Ribas-Latre, A. ; Schilling, O.* ; Brix, K.* ; Stumvoll, M. ; Klöting, N. ; Heiker, J.T. ; Blüher, M.
Role of kallikrein 7 in body weight and fat mass regulation.
Biomedicines 9:131 (2021)
Increased plasma and adipose tissue protease activity is observed in patients with type 2 diabetes and obesity. It has been proposed that specific proteases contribute to the link between obesity, adipose tissue inflammation and metabolic diseases. We have recently shown that ablation of the serine protease kallikrein-related peptidase 7 (Klk7) specifically in adipose tissue preserves systemic insulin sensitivity and protects mice from obesity-related AT inflammation. Here, we investigated whether whole body Klk7 knockout (Klk7-/-) mice develop a phenotype distinct from that caused by reduced Klk7 expression in adipose tissue. Compared to littermate controls, Klk7-/- mice gain less body weight and fat mass both under chow and high fat diet (HFD) feeding, are hyper-responsive to exogenous insulin and exhibit preserved adipose tissue function due to adipocyte hyperplasia and lower inflammation. Klk7-/- mice exhibit increased adipose tissue thermogenesis, which is not related to altered thyroid function. These data strengthen our recently proposed role of Klk7 in the regulation of body weight, energy metabolism, and obesity-associated adipose tissue dysfunction. The protective effects of Klk7 deficiency in obesity are likely linked to a significant limitation of adipocyte hypertrophy. In conclusion, our data indicate potential application of specific KLK7 inhibitors to regulate KLK7 activity in the development of obesity and counteract obesity-associated inflammation and metabolic diseases.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Klk7 ; Adipose Tissue ; Inhibitor ; Kallikrein-related Peptidase 7 ; Metabolic Disease ; Obesity ; Protease ; Treatment
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
2227-9059
e-ISSN
2227-9059
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 9,
Issue: 2,
Pages: ,
Article Number: 131
Supplement: ,
Series
Publisher
MDPI
Publishing Place
Basel, Switzerland
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-506501-001
G-506500-001
G-554800-001
Grants
Helmholtz Alliance ICEMED
Bundesministerium für Bildung und Forschung
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2021-04-19